TC Biopharm (Holdings) Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

210.31K USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	3.84M	1.87M	94.30%
Dec 31, 2021	1.98M	-	-
Dec 31, 2020	1.98M	-1.45M	-42.26%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
American Oncology Network	1.76B
Veradigm	588.02M
Glass House Brands	196.17M
Global Cord Blood	196.10M
Elite Pharmaceuticals	122.89M
Silence Therapeutics	25.83M
OpGen	9.00M
Northwest Biotherapeutics	937.00K

Revenue Rankings

TC Biopharm (Holdings) News

7 months ago - TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient - PRNewsWire
9 months ago - TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells - PRNewsWire
10 months ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
10 months ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
10 months ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
11 months ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
11 months ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
11 months ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire

More News